Now I have all the information I need. Let me construct the final consolidated review.

## Summary

This paper introduces LICO, a method that extends pretrained LLMs to serve as surrogate models for black-box molecular optimization. LICO equips a frozen LLM with learned embedding layers (for molecules and scores) and a prediction head, then trains the model on a mixture of intrinsic molecular properties and GP-generated synthetic functions to perform in-context predictions. On the 21-task PMO benchmark, LICO achieves the highest aggregate score (10.760) and best mean rank (1.48), outperforming GP BO, Graph GA, REINVENT, and TNP.

## Strengths

- **State-of-the-art performance on PMO**: Table 1 shows LICO achieves the highest sum of scores (10.760 vs. 10.313 for GP BO, the next best) and lowest mean rank (1.48 vs. 2.33) across 21 tasks, winning 12/21 tasks outright and placing second on 8/21. This is direct evidence for the paper's central claim.

- **Semi-synthetic training design is well-motivated and ablated**: The paper clearly motivates why intrinsic functions alone risk overfitting to known properties while synthetic functions alone lack domain relevance. Table 3 (ablation on synthetic ratio) shows the semi-synthetic variant (0.1 ratio) achieves the highest sum (3.099) vs. intrinsic-only (3.010) and synthetic-only (2.936), supporting the claim that both components contribute.

- **Pretrained LLM advantage is clearly demonstrated**: Table 4 shows LICO with pretrained Llama-2-7b (sum 3.099) substantially outperforms an identically-sized scratch transformer (2.898), and Figure 2 shows optimization performance scales consistently with LLM size (Qwen-1.8B < 2.7B < 4B < 7B). These results validate the core premise that language pretraining provides transferable pattern-matching capabilities.

- **Clear distinction from prior work**: The paper articulates well why LICO differs from existing LLM-for-optimization methods (which operate in text space, limiting generality) and from FPT (which lacks language instructions for in-context learning). The ablation on language instructions (Table 2) supports this distinction.

## Weaknesses

### Fatal
None.

### Major

- **Factual error in the predictive-alignment analysis (Section 7, Figure 3, Table 1)**: The paper states: *"In median1 and ranolazine\_mpo where LICO outperforms GP in terms of optimization score, the model also achieves lower negative log-likelihood, mean squared error, and calibration error."* This is factually wrong for ranolazine\_mpo: Table 1 shows GP BO = 0.701 ± 0.023, LICO = 0.687 ± 0.029 — GP outperforms LICO. The claim that "optimization performance closely aligns with predictive performance" therefore rests entirely on median1 (where scores are essentially tied: 0.217 vs. 0.213) and one correct negative case (troglitazone\_rediscovery). This weakens the argument that LICO's superior surrogate modeling is the identified mechanism behind its optimization advantage. The authors should correct this error and either remove or qualify the ranolazine\_mpo claim accordingly.

### Minor

- **Language instruction ablation lacks statistical support (Table 2)**: The differences across the three variants (w/o Language, w/o Task prompt, full) are small on individual tasks and standard deviations substantially overlap — e.g., albuterol\_similarity: 0.615 ± 0.104 vs. 0.656 ± 0.125. The aggregate sums (2.927 → 3.060 → 3.099) show a trend, but without statistical tests or more seeds, the paper's conclusion that language instruction is "important" is not strongly supported by the data as presented.

- **Synthetic ratio ablation shows modest differences (Table 3)**: The improvement of the best semi-synthetic variant (0.1, sum 3.099) over intrinsic-only (3.010) is only ~3% relative, and standard deviations overlap on individual tasks. The "large margin" benefit on albuterol\_similarity (0.598 vs. 0.656) is the main driver, but still within 1 standard deviation. The narrative that synthetic data is "crucial" is somewhat overstated relative to the evidence.

- **Set of intrinsic functions is not fully specified**: The paper gives examples ("molecular weight, number of rings, heavy atom count") but never lists the complete set or states the total count. Since the intrinsic function set is a core design component and the paper's main differentiator from ExPT, this information is needed for reproducibility and to assess generalization claims.

- **Acquisition function not specified**: The optimization procedure (Section 4.3) mentions "an acquisition function α" that balances exploitation and exploration, but never names the acquisition function used (UCB, EI, Thompson sampling, etc.). This affects reproducibility.

- **Choice of 0.1 synthetic ratio is not justified**: The paper selects this value but does not explain how it was determined (e.g., via held-out validation) or discuss whether the optimal ratio varies by task.

- **Predictive comparison limited to 3 tasks (Figure 3)**: The alignment analysis between predictive and optimization performance covers only 3 of 21 tasks. One of these (ranolazine\_mpo) contains the factual error above, and another (median1) shows near-tied optimization scores. Expanding this analysis would strengthen the mechanism argument.

### Trivial

- The factual error in Section 7 (described above under Major) is also a presentation error.
- On fexofenadine\_mpo, osimertinib\_mpo, and thiothixene\_rediscovery, GP BO actually outperforms LICO numerically — reporting exactly 12/21 best and 8/21 second-best might be slightly imprecise (some tasks have GP BO as best and LICO as second-best), but this does not affect the aggregate conclusion.

## Nice-to-Haves

- Report results with the original (unmodified) GP BO as well, to quantify the impact of the candidate-generation improvement transparently.
- Provide confidence intervals or bootstrap-based significance tests for the main task comparisons.
- Clarify why the budget was reduced to 1000 (vs. PMO's 10000) and discuss whether rankings would change at the higher budget.

## Removed Points

These points are flagged to be removed; treat them with caution:

- **"Unfair baseline comparison" (Harsh Critic Issue 2)**: The critic claimed the improved GP BO makes the comparison unfair. This is incorrect. The paper transparently states it improved GP BO's candidate generation, making it *stronger*. Comparing against a stronger baseline is more rigorous, not less. The critic's logic — that this invalidates the SOTA claim — does not hold; LICO still beats the improved GP BO (10.760 vs. 10.313), and the improvement only makes the comparison harder for LICO.

- **"Scratch transformer comparison does not isolate pretraining effect"**: The scratch model uses a transformer architecture (from Garg et al., 2022) designed for in-context learning — same architecture family as Llama-2. The comparison reasonably isolates the effect of pretrained weights.

- **"Modest synthetic ratio difference" framed as structural**: This is already captured as a Minor weakness (see above). The critic's framing as more severe is unwarranted — the trend across four conditions (intrinsic → 0.1 → 0.5 → synthetic) is consistent and the aggregate sums differ.

- **General category-sweep concerns** (e.g., "could the metric be measuring a proxy?", generic evaluation rigor concerns without specific anchors): Removed per filtering discipline.

## Novel Insights

None beyond the paper's own contributions. The reviews did not surface a perspective that meaningfully reinterprets the paper's findings or reveals a connection the authors missed.

## Suggestions

1. **Correct the factual error** on line 175: remove the claim that LICO outperforms GP BO on ranolazine\_mpo, or add a qualifier that the difference is small and within error bars.
2. **Specify the complete set of intrinsic functions** used during training (in appendix or main text).
3. **Name the acquisition function** used in the optimization loop.
4. **Add statistical tests** (or at minimum note the absence) for the language instruction and synthetic ratio ablations.

## Score and Decision

MY FINAL SCORE: <score>7.0</score>
MY FINAL DECISION: <decision>Accept</decision>